Terms ending in 2033
Every in-force patent on Biogen Ma Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,676,849 | Enhancement of Transport of Therapeutic Molecules Across the Blood Brain Barrier In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,286,528 | Methods of Reducing Immunogenicity Against Factor VIII in Individuals Undergoing Factor VIII Therapy In force · High confidence | Bioverativ Therapeutics Inc. | In force | High confidence | |
| US 9,216,987 | Chroman Derivative In force · High confidence | Corxel Pharmaceuticals Hong Kong Limited | In force | High confidence | |
| US 9,233,107 | Compositions and Methods for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 10,273,474 | Methods for Modulating Tau Expression for Reducing Seizure and Modifying a Neurodegenerative Syndrome In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,781,135 | Methods for Treating Alzheimer's Disease In force · High confidence | Washington University | In force | High confidence | |
| US 9,567,391 | JCV Neutralizing Antibodies In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,567,392 | JCV Neutralizing Antibodies In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,266,843 | Nuclear Transport Modulators and Uses Thereof In force · High confidence | Karyopharm Therapeutics Inc. | In force | High confidence | |
| US 9,585,874 | Nuclear Transport Modulators and Uses Thereof In force · High confidence | Karyopharm Therapeutics Inc. | In force | High confidence | |
| 31 more term ends in 2033 · Pro | |||||
10 of 41 patents shown. Soonest term end first, then patent number.
Pro members see all 41.
19 of these are in force and held by Biogen Ma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.